
About Reenav Pharma Private Limited
Data last updated:
Reenav Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ascent Wellness And Pharma Solutions Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC308208. Its GSTIN is 27AAICR8983Q1Z4 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Arvind Govind Varia and Rajeshree Trikamlal Gor.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 607 6th Floor Skyline Epitome Building Near Jolly Gymkhana Vidyavihar West, Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹12.7 Lakh (net margin 5.7%) and EBITDA of ₹27.4 Lakh (EBITDA margin 12.4%). Revenue has declined at a compounded annual rate (CAGR) of 78% over three years and 50% over five years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Negbuy Private Limited with revenue of ₹2.22 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier.
For more details, the company can be reached via its website reenavpharma.com.
Company details
Contact details
Reenav Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is reenavpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address607 6th Floor Skyline Epitome Building Near Jolly Gymkhana Vidyavihar West, Mumbai, Maharashtra, India – 400086
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Reenav Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reenav Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reenav Pharma Private Limited, buy the company report.
Financials of Reenav Pharma Private Limited
FY 2024 filings availableReenav Pharma Private Limited reported revenue of ₹2.22 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 50%. EBITDA rose 226% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reenav Pharma Private Limited, buy the company report.
Board of directors of Reenav Pharma Private Limited
Reenav Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Govind Varia Also directs: Reenav Logistics Private Limited | Director | 18 Apr 2018 | 8 Years 7 Months | Current |
| Rajeshree Trikamlal Gor Also directs: Reenav Logistics Private Limited | Director | 18 Apr 2018 | 8 Years 7 Months | Current |
Peer comparison
Reenav Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Negbuy Private Limited | ₹2.22 Cr (FY 2025) | -68.0% | Delhi, India | |||
| Shivshakti Agencies Private Limited | ₹2.22 Cr (FY 2024) | 8.0% | Uluberia, West Bengal, India | |||
| MTC Disposable Eco Products Private Limited | ₹2.22 Cr (FY 2024) | -23.0% | Surat, Gujarat, India | |||
| Hemalite Products Private Limited | ₹2.22 Cr (FY 2016) | 27.0% | Chennai, Tamil Nadu, India | |||
| Sisumara Trading Private Limited | ₹2.22 Cr (FY 2018) | Kolkata, West Bengal, India | ||||
| Reenav Pharma Private Limitedthis company | ₹2.22 Cr (FY 2025) | ₹12.7 Lakh | 5.7% | 9.0% | Mumbai, Maharashtra, India | |
| Opus Innovation Private Limited | ₹2.21 Cr (FY 2024) | 69.0% | Mumbai, Maharashtra, India | |||
| Rd Strategic Esales Private Limited | ₹2.21 Cr (FY 2017) | -8.0% | Mumbai, Maharashtra, India | |||
| Avigenix Innovations Private Limited | ₹2.21 Cr (FY 2024) | 57.0% | Kolkata, West Bengal, India | |||
| Kokane Farmer Producer Company Limited | ₹2.21 Cr (FY 2025) | 177.0% | Nanded, Maharashtra, India | |||
| Richa Paints and Stones Private Limited | ₹2.21 Cr (FY 2025) | -4.0% | Kota, Rajasthan, India |
To see the full peer comparison of Reenav Pharma Private Limited, buy the company report.
Auditor
Reenav Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Reenav Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Reenav Pharma Private Limited, buy the company report.
Deals & funding
Reenav Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Ascent Wellness and Pharma Solutions Private Limited Seller: Api Holdings Limited |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: Api Holdings Limited Seller: Ascent Health and Wellness Solutions Private Limited |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Ascent Health and Wellness Solutions Private Limited Seller: 2 individuals |
| Nov 2018 | Debt financing | ₹1.2 Cr | Investors: Ascent Health and Wellness Solutions Private Limited |
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: Ascent Health and Wellness Solutions Private Limited Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Reenav Pharma Private Limited has 1 court case on record: 1 filed by Reenav Pharma. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
To see the full case history of Reenav Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Reenav Pharma Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Miraclus Orthotech Private Limited |
To see the full MSME payment records of Reenav Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Reenav Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR8983Q1Z4 | Maharashtra | Active | 28 Jun 2018 |
To see the full GST registrations and return filing status of Reenav Pharma Private Limited, buy the company report.
Recent activity
Reenav Pharma Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Anand Subramanian Iyer ceased to be Additional Director on 24 Sep 2022.
Frequently asked questions
Reenav Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 April 2018 (8+ years old) and is registered under CIN U74999MH2018PTC308208.
Reenav Pharma has 2 current directors:
- Arvind Govind Varia - Director
- Rajeshree Trikamlal Gor - Director
The latest financial statements of Reenav Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Reenav Pharma is 27AAICR8983Q1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Reenav Pharma is U74999MH2018PTC308208. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reenav Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Reenav Pharma was incorporated on 18 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Reenav Pharma has 5 deals on record (4 secondary share transfers, 1 debt financing), with disclosed funding of ₹1.2 Cr; the latest was in August 2020.
The peers of Reenav Pharma by revenue are Negbuy Private Limited, Shivshakti Agencies Private Limited, MTC Disposable Eco Products Private Limited, Hemalite Products Private Limited, Sisumara Trading Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anand Subramanian Iyer ceased to be Additional Director on 24 Sep 2022. Kalpana Srinivasan ceased to be Additional Director on 24 Sep 2022. Jay Rajesh Mehta ceased to be Director on 13 May 2022. Reenav Pharma has 5 board changes on record in total.
Reenav Pharma has 4 MSME Form 1 returns on record between 2019 and 2020, listing 52 overdue payments to 1 micro and small supplier. The latest return was filed on 30 Jan 2021.
Reenav Pharma can be reached through the website reenavpharma.com. Its registered office is in Mumbai, Maharashtra, India.

